Risk of Cardiovascular Events After COVID-19

We aimed to determine absolute and relative risks of either symptomatic or asymptomatic SARS-CoV-2 infection for late cardiovascular (CV) events and all-cause mortality. We conducted a retrospective double cohort study of patients with either symptomatic or asymptomatic SARS-CoV-2 infection (COVID-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Tereshchenko, Larisa G., Bishop, Adam, Fisher-Campbell, Nora, Levene, Jacqueline, Morris, Craig C., Patel, Hetal, Beeson, Erynn, Blank, Jessica A., Bradner, JG N., Coblens, Michelle, Corpron, Jacob W., Davison, Jenna M., Denny, Kathleen, Earp, Mary S., Florea, Simeon, Freeman, Howard, Fuson, Olivia, Guillot, Florian H., Haq, Kazi T., Kim, Morris, Kolseth, Clinton, Krol, Olivia, Lin, Lisa, Litwin, Liat, Malik, Aneeq, Mitchell, Evan, Mohapatra, Aman, Mullen, Cassandra, Nix, Chad D, Oyeyemi, Ayodele, Rutlen, Christine, Tam, Ashley E., Van Buren, Inga, Wallace, Jessica, Khan, Akram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282909/
https://www.ncbi.nlm.nih.gov/pubmed/35843735
http://dx.doi.org/10.1016/j.amjcard.2022.06.023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282909/
https://www.ncbi.nlm.nih.gov/pubmed/35843735
http://dx.doi.org/10.1016/j.amjcard.2022.06.023

Ejemplares similares